PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-147426 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Pharmaceutical, Biologics, Small Molecules and Gene Therapy Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET
7.1 GLOBAL PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA PHARMACEUTICAL, BIOLOGICS, SMALL MOLECULES AND GENE THERAPY MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Beximco Pharma
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Cadila Healthcare
16.3 SQUARE
16.4 Renata
16.5 Orion Pharma
16.6 Alkem
16.7 Amgen
16.8 Novartis AG
16.9 Pfizer Inc
16.10 F Hoffman-La Roche AG
16.11 SANOFI
16.12 Aristopharma
16.13 Glenmark
16.14 AbbVie Inc
16.15 AstraZeneca
16.16 B Braun
16.17 Aurobindo Pharm
16.18 Torrent Pharma
16.19 GSK
16.20 Sun Pharmaceuticals
16.21 Dr Reddy's
16.22 Cipla
16.23 Bayer AG
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypePharmaceutical
Biologics
Small Molecules
Gene Therapy
By Application
Hospital
Clinic
Others
Companies
Beximco Pharma
Cadila Healthcare
SQUARE
Renata
Orion Pharma
Alkem
Amgen
Novartis AG
Pfizer Inc
F Hoffman-La Roche AG
SANOFI
Aristopharma
Glenmark
AbbVie Inc
AstraZeneca
B Braun
Aurobindo Pharm
Torrent Pharma
GSK
Sun Pharmaceuticals
Dr Reddy's
Cipla
Bayer AG
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.